Press Releases

Introducing Freyr ARTWORK 360

Freyr has announced an exclusive artwork lifecycle management tool that will significantly emphasise end-to-end automation of creative and compliant artwork solutions and simplify the review process through a better graphic collaboration using a built-in annotation tool.

World Gynecologic Oncology Awareness Day (World GO Day): On September 20, 2022, turn the globe purple!

ESGO has announced a new challenge for World Gynecologic Oncology Awareness Day, to inspire and motivate women all around the world to improve their health by incorporating regular physical activity into their daily routine.

Trinity Health Partners with Orexo US to Expand Patient Access to Digital Therapeutics

Cytel expansion unlocks innovative clinical development expertise for APAC biopharma sector

Cytel Inc. has expanded its operations into the Asia-Pacific region (APAC).

“Genome Editing of Immune Cells” - New Lonza Virtual Event

Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.

mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022

mdgroup Chief Operating Officer LaQuinta Jernigan Honoured as one of 100 Most Inspiring People in Life Sciences 2022 Recognized for championing diversity and collaboration within the clinical trials industry

Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections

Takara Bio Europe announced today a partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.

CapnoPharm awarded as drug delivery platform Capnodrug® reaches finals of Reuters Pharma Europe Award 2022

CapnoPharm is proud to announce its selection as Finalist of the prestigious Reuters Pharma Europe Award 2022 for its Cancer drug delivery innovation - Capnodrug® - in the Health Entrepreneur Award category.

Sakura Finetek offers the optimal advanced stained slide with the new Tissue-Tek Genie®

Sakura Finetek Europe has announced the launch of its newest solution Tissue-Tek Genie, an Advanced staining system.

Medix Biochemica Appoints Dr. Michele Pedrocchi, Former Head of Business Development for Roche Diagnostics, to its Board of Directors

Medix Biochemica has announced the appointment of Dr. Michele Pedrocchi to their Board of Directors.

Hydrophilic Polymers Exhibit Boundless Opportunities for Multiple Fields

Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals

Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Needs

Creative Biogene Updates Gene Knockout Services for C-elegans Using Mos 1-Mediated Deletion Method

BOC Sciences Developed Strain Expression Systems to Enhance Fermentation Productivity

PseudoUridine Phosphoramidites for Efficient and Reliable Syntheses of RNA Oligonucleotides

Clinical trials legal service provider cements expansion plans with first US office

Clinical trials legal service provider cements expansion plans with first US office CTA Focus’ North Carolina base will provide seamless access to world-class services

Curebase Names Digital Infrastructure Veteran Matt Lanier as VP of Engineering

Curebase, a company committed to democratizing access to clinical studies, has named veteran digital infrastructure executive Matt Lanier as vice president of engineering.

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future

Industry-leading Risk-Based Quality Management event focuses on the maturity of RBQM, its increasing value, and the vision for the future CluePoints Hosts RBQM Live 2022 as the Premier Event Sponsor

Rho Announces Findings from Study it Coordinated to Explore Therapy for Reducing Asthma Attacks Among Disadvantaged Urban Youth

Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced findings from a clinical trial it supported as the Statistical and Clinical Coordinating Center for the Inner-City Asthma Consortium (ICAC) to assess the efficacy of a monoclonal antibody for reducing asthma attacks in disadvantaged urban youth.